Damora Therapeutics annual total assets
2019
2020
2021
2022
2023
2024
2025
Damora Therapeutics Total Assets Growth & History (DMRA)
Damora Therapeutics's total assets was $260.5M for fiscal 2025.
View full Damora Therapeutics company overviewDamora Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $260.5M | $243.4M | +1420.70% |
| 2024 | 2024-12-31 | $17.1M | −$21.1M | −55.18% |
| 2023 | 2023-12-31 | $38.2M | −$35.0M | −47.77% |
| 2022 | 2022-12-31 | $73.2M | −$49.0M | −40.12% |
| 2021 | 2021-12-31 | $122.2M | −$49.4M | −28.78% |
| 2020 | 2020-12-31 | $171.6M | $115.0M | +203.12% |
| 2019 | 2019-12-31 | $56.6M | — | — |
Damora Therapeutics quarterly total assets
Q4.19
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $543.6M | $529.9M | +3870.75% |
| Q1 2026 | 2026-03-31 | $535.4M | $520.1M | +3384.82% |
| Q4 2025 | 2025-12-31 | $260.5M | $243.4M | +1420.70% |
| Q3 2025 | 2025-09-30 | $10.7M | −$12.6M | −54.07% |
| Q2 2025 | 2025-06-30 | $13.7M | −$13.6M | −49.84% |
| Q1 2025 | 2025-03-31 | $15.4M | −$17.1M | −52.69% |
| Q4 2024 | 2024-12-31 | $17.1M | −$21.1M | −55.18% |
| Q3 2024 | 2024-09-30 | $23.4M | −$26.7M | −53.29% |
| Q2 2024 | 2024-06-30 | $27.3M | −$31.5M | −53.58% |
| Q1 2024 | 2024-03-31 | $32.5M | −$32.2M | −49.75% |
| Q4 2023 | 2023-12-31 | $38.2M | −$35.0M | −47.77% |
| Q3 2023 | 2023-09-30 | $50.0M | −$32.0M | −38.98% |
| Q2 2023 | 2023-06-30 | $58.8M | −$34.1M | −36.67% |
| Q1 2023 | 2023-03-31 | $64.6M | −$44.3M | −40.67% |
| Q4 2022 | 2022-12-31 | $73.2M | −$49.0M | −40.12% |
| Q3 2022 | 2022-09-30 | $82.0M | −$53.8M | −39.63% |
| Q2 2022 | 2022-06-30 | $92.9M | −$54.0M | −36.75% |
| Q1 2022 | 2022-03-31 | $108.9M | −$49.7M | −31.34% |
| Q4 2021 | 2021-12-31 | $122.2M | −$49.4M | −28.78% |
| Q3 2021 | 2021-09-30 | $135.9M | $37.7M | +38.43% |
| Q2 2021 | 2021-06-30 | $146.8M | — | — |
| Q1 2021 | 2021-03-31 | $158.7M | — | — |
| Q4 2020 | 2020-12-31 | $171.6M | $115.0M | +203.12% |
| Q3 2020 | 2020-09-30 | $98.2M | — | — |
| Q4 2019 | 2019-12-31 | $56.6M | — | — |
Damora Therapeutics total assets trends
Over the last five fiscal years, Damora Therapeutics's total assets increased from $171.6M to $260.5M, a change of $88.9M. The latest reported quarter, Q2 2026, shows $543.6M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Damora Therapeutics source filings ↗